Stay updated on Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page
- Check4 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check10 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content with an error page. This prevents viewing the trial details and related information that the page is meant to provide.SummaryDifference19%

- Check53 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6, indicating a small release of the page infrastructure.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, reflecting a minor site update. The change represents an infrastructure or formatting update rather than a modification to study details or participant information.SummaryDifference0.0%

- Check88 days agoChange DetectedThe page shows a revision update from v3.6.3 to v3.6.4, indicating a software release. This update does not affect the study details or content presented on the page.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page.